Cargando…
Adult Heights of 258 Girls with Turner Syndrome on Low Dose of Growth Hormone Therapy in Japan
Growth hormone (GH) therapy was approved in 1999 for only GH-deficient Turner syndrome (TS) in Japan. It was subsequently approved for all cases of TS regardless of GH secretory status since 1999. The dose of GH is 1.0 u (0.35 mg)/kg/wk at present, but it was 0.5 u (0.175 mg)/kg/wk before 1999. The...
Autores principales: | Fujita, Keinosuke, Yokoya, Susumu, Fujieda, Kenji, Shimatsu, Akira, Tachibana, Katsuhiko, Tanaka, Hiroaki, Tanizawa, Takakuni, Teramoto, Akira, Nishi, Yoshikazu, Hasegawa, Yukihiro, Hanew, Kunihiko, Horikawa, Reiko, Nagai, Toshiro, Tanaka, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687621/ https://www.ncbi.nlm.nih.gov/pubmed/23926381 http://dx.doi.org/10.1297/cpe.19.63 |
Ejemplares similares
-
No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short
Children with GH Treatment
por: Tanaka, Toshiaki, et al.
Publicado: (2006) -
Favorable Impact of Growth Hormone Treatment on Cholesterol Levels in Turner
Syndrome
por: Kohno, Hitoshi, et al.
Publicado: (2012) -
Frequencies of spontaneous breast development and spontaneous menarche in
Turner syndrome in Japan
por: Tanaka, Toshiaki, et al.
Publicado: (2015) -
Effects of financial support on treatment of adolescents with growth hormone deficiency: a retrospective study in Japan
por: Maeda, Eri, et al.
Publicado: (2016) -
Standardization of Blood Growth Hormone Levels Measured by Different Kits
Using a Linear Structural Relationship
por: Saito, Tomohiro, et al.
Publicado: (2006)